Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance

Clinical Pharmacokinetics

Volumn 51, Issue 2, 2012, Pages 105-117

  De Cock, Roosmarijn F W ^a   Allegaert, Karel ^b   Schreuder, Michiel F ^c   Sherwin, Catherine M T ^d   De Hoog, Matthijs ^e   Van Den Anker, Johannes N ^e,f   Danhof, Meindert ^a   Knibbe, Catherijne A J ^a,g  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Amikacin; Aminoglycosides; Glomerular filtration rate; Neonates; Pharmacokinetic modelling; Pharmacokinetics; Pharmacology

Indexed keywords

AMIKACIN; IBUPROFEN;

ALLOMETRY; ARTICLE; BIRTH WEIGHT; DOSE RESPONSE; DRUG CLEARANCE; EXTERNAL VALIDITY; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; MENSTRUATION; NEWBORN; PREMATURITY; PRIORITY JOURNAL; TERM BIRTH;

AGE FACTORS; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; CHILD DEVELOPMENT; COMPUTER SIMULATION; DRUG INTERACTIONS; GLOMERULAR FILTRATION RATE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY GLOMERULUS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; PREMATURE BIRTH; RENAL INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 84855910834     PISSN: 03125963     EISSN: 11791926     Source Type: Journal    
DOI: 10.2165/11595640-000000000-00000     Document Type: Article

References (47)

1. Allegaert K, Anderson BJ, Cossey V, et al. Limited predictability of amikacin clearance in extreme premature neonates at birth. Br J Clin Pharmacol 2006 Jan; 61 (1): 39-48 (Pubitemid 43381236)
2. Allegaert K, Scheers I, Cossey V, et al. Covariates of amikacin clearance in neonates: the impact of postnatal age on predictability. Drug Metab Lett 2008 Dec; 2 (4): 286-9
3. Nielsen EI, Sandstrom M, Honore PH, et al. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clin Pharmacokinet 2009; 48 (4): 253-63
4. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009 Jan; 24 (1): 67-76
5. Capparelli EV, Lane JR, Romanowski GL, et al. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol 2001 Sep; 41 (9): 927-34 (Pubitemid 32786565)
6. Sherwin CM, Svahn S, Van der Linden A, et al. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. Eur J Clin Pharmacol 2009 Jul; 65 (7): 705-13
7. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003 Sep 18; 349 (12): 1157-67 (Pubitemid 37122329)
8. Bartelink IH, Rademaker CM, Schobben AF, et al. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45 (11): 1077-97 (Pubitemid 44631388)
9. Chen N, Aleksa K, Woodland C, et al. Ontogeny of drug elimination by the human kidney. Pediatr Nephrol 2006 Feb; 21 (2): 160-8 (Pubitemid 43115865)
10. Work DF, Schwartz GJ. Estimating and measuring glomerular filtration rate in children. Curr Opin Nephrol Hypertens 2008 May; 17 (3): 320-5 (Pubitemid 351535937)
11. Traynor J, Mactier R, Geddes CC, et al. How to measure renal function in clinical practice. BMJ 2006 Oct 7; 333 (7571): 733-7 (Pubitemid 44555171)
12. Swinkels DW, Hendriks JC, Nauta J, et al. Glomerular filtration rate by singleinjection inulin clearance: definition of a workable protocol for children. Ann Clin Biochem 2000 Jan; 37 (Pt 1): 60-6 (Pubitemid 30064226)
13. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med 1988; 39: 465-90 (Pubitemid 19090815)
14. van Rossum LK, Cransberg K, de Rijke YB, et al. Determination of inulin clearance by single injection or infusion in children. Pediatr Nephrol 2005 Jun; 20 (6): 777-81 (Pubitemid 40663162)
15. George I, Levtchenko E, Rayyan M, et al. Renal impairment in ELBW infants can be defined on day 3 [abstract no. 892]. Pediatr Nephrol 2010 Sep; 25 (9): 1973
16. Bueva A, Guignard JP. Renal function in preterm neonates. Pediatr Res 1994 Nov; 36 (5): 572-7 (Pubitemid 24331359)
17. Pierrat A, Gravier E, Saunders C, et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and Modification of Diet in Renal Disease formulas. Kidney Int 2003 Oct; 64 (4): 1425-36 (Pubitemid 37153809)
18. Koren G, James A, Perlman M. A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther 1985 Dec; 38 (6): 680-5 (Pubitemid 16124382)
19. Landers S, Berry PL, Kearns GL, et al. Gentamicin disposition and effect on development of renal function in the very low birth weight infant. Dev Pharmacol Ther 1984; 7 (5): 285-302 (Pubitemid 14098485)
20. Schreuder MF, Wilhelm AJ, Bokenkamp A, et al. Impact of gestational age and birth weight on amikacin clearance on day 1 of life. Clin J Am Soc Nephrol 2009 Nov; 4 (11): 1774-8
21. Langhendries JP, Battisti O, Bertrand JM, et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate 1998 Nov; 74 (5): 351-62 (Pubitemid 28461753)
22. Krekels EH, van Hasselt JG, Tibboel D, et al. Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models. Pharm Res 2011 Apr; 28 (4): 797-811
23. Montgomery DC, Peck EA. Introduction to linear regression analysis. New York: Wiley, 1982: 301-2
24. Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther 2007 Jul; 82 (1): 17-20 (Pubitemid 46944205)
25. Allegaert K, Debeer A, Cossey V, et al. Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants. Pediatr Crit Care Med 2006 Mar; 7 (2): 143-6
26. Brendel K, Comets E, Laffont C, et al. Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide. Pharm Res 2006 Sep; 23 (9): 2036-49
27. Comets E, Brendel K, Mentre F. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the NPDE addon package for R. Comput Methods Programs Biomed 2008 May; 90 (2): 154-66
28. Young TE, Magnum B. Neofax. 23rd ed. Montvale (NJ): Thomson Reuters, 2010
29. American Academy of Pediatrics. Red Book. 28th ed. Elk Grove Village (IL): American Academy of Pediatrics, 2009
30. British National Formulary for Children. London: BMJ Group, 2009
31. De Hoog M, van den Anker J. Aminoglycosides and glycopeptides. In: Yaffe SJ, Aranda JV, editors. Neonatal and pediatric pharmacology: therapeutic principles in practice. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins, 2010: 412-35
32. Touw DJ, Westerman EM, Sprij AJ. Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet 2009; 48 (2): 71-88
33. Avent ML, Kinney JS, Istre GR, et al. Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen. Am J Perinatol 2002 Nov; 19 (8): 413-20
34. Hughson M, Farris 3rd AB, Douglas-DentonR, et al. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 2003 Jun; 63 (6): 2113-22 (Pubitemid 36605822)
35. Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2007 Jan; 63 (1): 75-84 (Pubitemid 44902880)
36. Allegaert K, Anderson BJ, van den Anker JN, et al. Renal drug clearance in preterm neonates: relation to prenatal growth. Ther Drug Monit 2007 Jun; 29 (3): 284-91 (Pubitemid 47262257)
37. Treluyer JM, Merle Y, Tonnelier S, et al. Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children. Antimicrob Agents Chemother 2002 May; 46 (5): 1381-7 (Pubitemid 34415318)
38. Petersen PO, Wells TG, Kearns GL. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data. Dev Pharmacol Ther 1991; 16 (4): 203-11
39. Fanos V, Benini D, Verlato G, et al. Efficacy and renal tolerability of ibuprofen vs indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005 Apr; 19 (2): 187-93 (Pubitemid 40524118)
40. Allegaert K, Rayyan M, Anderson BJ. Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Methods Find Exp Clin Pharmacol 2006 Oct; 28 (8): 519-22 (Pubitemid 44885381)
41. Allegaert K, Vanhole C, de Hoon J, et al. Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005 Nov; 20 (11): 1557-61 (Pubitemid 41554465)
42. Thomas RL, Parker GC, Van Overmeire B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005 Mar; 164 (3): 135-40 (Pubitemid 40558175)
43. van den Anker JN, de Groot R, Broerse HM, et al. Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with inulin clearance. Pediatrics 1995 Dec; 96 (6): 1156-8
44. Fawer CL, Torrado A, Guignard JP. Maturation of renal function in full-term and premature neonates. Helv Paediatr Acta 1979 Feb; 34 (1): 11-21 (Pubitemid 9111122)
45. van der Heijden AJ, Grose WF, Ambagtsheer JJ, et al. Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Pediatr 1988 Oct; 148 (1): 24-8
46. Ealy M, Lynch KA, Meyer NC, et al. The prevalence of mitochondrial mutations associated with aminoglycoside-induced sensorineural hearing loss in an NICU population. Laryngoscope 2011 Jun; 121 (6): 1184-6
47. AzzopardiD, Brocklehurst P, Edwards D, et al., the TOBY study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr 2008; 8: 17